| An update on current therapeutic drugs treating COVID-19 R Wu, L Wang, HCD Kuo, A Shannar, R Peter, PJ Chou, S Li, R Hudlikar, ... Current pharmacology reports 6, 56-70, 2020 | 653 | 2020 |
| Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory‐driven colon cancer R Wu, L Wang, R Yin, R Hudlikar, S Li, HCD Kuo, R Peter, D Sargsyan, ... Molecular carcinogenesis 59 (2), 227-236, 2020 | 80 | 2020 |
| Epigenetics/epigenomics of triterpenoids in cancer prevention and in health S Li, HCD Kuo, R Yin, R Wu, X Liu, L Wang, R Hudlikar, RM Peter, ... Biochemical pharmacology 175, 113890, 2020 | 47 | 2020 |
| Butyrate drives metabolic rewiring and epigenetic reprogramming in human colon cancer cells L Wang, AAF Shannar, R Wu, P Chou, MS Sarwar, H Kuo, RM Peter, ... Molecular nutrition & food research 66 (12), 2200028, 2022 | 32 | 2022 |
| Redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals R Wu, S Li, R Hudlikar, L Wang, A Shannar, R Peter, PJ Chou, HCD Kuo, ... Free Radical Biology and Medicine 179, 328-336, 2022 | 32 | 2022 |
| Epigenetics/epigenomics and prevention of early stages of cancer by isothiocyanates R Hudlikar, L Wang, R Wu, S Li, R Peter, A Shannar, PJ Chou, X Liu, Z Liu, ... Cancer Prevention Research 14 (2), 151-164, 2021 | 20 | 2021 |
| An Update on Current Therapeutic Drugs Treating COVID-19//CurrPharmacol Rep. 2020 R Wu, L Wang, HD Kuo, A Shannar, R Peter, PJ Chou, S Li, R Hudlikar, ... DOI 10, 1-15, 0 | 14 | |
| An Update on Current Therapeutic Drugs Treating COVID-19. Current Pharmacology Reports, 6, 56-70 R Wu, L Wang, HCD Kuo, A Shannar, R Peter, PJ Chou, S Li, R Hudlikar, ... | 10 | 2020 |
| DNA methylome, transcriptome, and prostate cancer prevention by phenethyl isothiocyanate in TRAMP mice R Wu, S Li, D Sargsyan, R Yin, HC Kuo, R Peter, L Wang, R Hudlikar, ... Molecular carcinogenesis 60 (6), 391-402, 2021 | 8 | 2021 |
| An update on current therapeutic drugs treating COVID-19. Curr Pharmacol Rep. 2020; 6: 56–70 R Wu, L Wang, HCD Kuo, A Shannar, R Peter, PJ Chou | 6 | |
| Histone deacetylase inhibitor belinostat regulates metabolic reprogramming in killing KRAS‐mutant human lung cancer cells RM Peter, MS Sarwar, SZ Mostafa, Y Wang, X Su, AN Kong Molecular Carcinogenesis 62 (8), 1136-1146, 2023 | 2 | 2023 |
| The environmental carcinogen benzo [a] pyrene regulates epigenetic reprogramming and metabolic rewiring in a two-stage mouse skin carcinogenesis model MS Sarwar, CN Ramirez, HC Dina Kuo, P Chou, R Wu, D Sargsyan, ... Carcinogenesis 44 (5), 436-449, 2023 | 2 | 2023 |
| Anthocyanins and cancer prevention R Hudlikar, R Wu, D Cheng, DHC Kuo, L Wang, R Peter, R Yin, S Li, ... Natural products for cancer chemoprevention: single compounds and …, 2020 | 2 | 2020 |
| An update on potential molecular biomarkers of dietary phytochemicals targeting lung cancer interception and prevention RM Peter, PJ Chou, A Shannar, K Patel, Y Pan, PD Dave, J Xu, ... Pharmaceutical research 40 (11), 2699-2714, 2023 | 1 | 2023 |
| Triterpenoid ursolic acid regulates the environmental carcinogen benzo [a] pyrene-driven epigenetic and metabolic alterations in SKH-1 hairless mice for skin cancer interception MS Sarwar, CN Ramirez, HCD Kuo, P Chou, R Wu, D Sargsyan, Y Yang, ... Carcinogenesis, bgae009, 2024 | | 2024 |
| Metabolic rewiring and epigenetic reprogramming in leptin receptor-deficient db/db diabetic nephropathy mice MS Sarwar, D Cheng, RM Peter, A Shannar, P Chou, L Wang, R Wu, ... European Journal of Pharmacology 953, 175866, 2023 | | 2023 |
| Metabolic rewiring and epigenetic reprogramming by the environmental carcinogen benzo [a] pyrene in a two-stage skin carcinogenesis mouse model and cancer interception by … MS Sarwar, CN Ramirez, HCD Kuo, P Chou, R Wu, D Sargsyan, ... Cancer Research 83 (7_Supplement), 5266-5266, 2023 | | 2023 |
